LENZ
LENZ Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.08 / 10
Netural
Fund-flow sentiment is positive (7.95/10), with overall, block, small, large, and extra-large inflows leaning bullish, though medium inflows are negative. Analyst consensus is overwhelmingly Buy (2 out of 2), but historical win rates are only 50%, and the current price trend is falling (-13.50%). This divergence between positive liquidity and weak price action calls for monitoring before committing capital.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-10
InstitutionPiper Sandler
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for LENZ?
- LENZ holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.08/10 (Netural).
